ANI Pharmaceuticals adds Henry Gosebruch to board, Shanmugam resigns directorship
The rare disease-focused drugmaker named a longtime AbbVie strategy executive to its board effective August 19, 2026, as a current director stepped down from the board while keeping his executive role.
SEC filing